Demographics (2)
- AGE - Age at Diagnosis (phv00543997.v1.p1)
- SEX - Biological sex (phv00543990.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Is subject affected by brain cancer (phv00543994.v1.p1)
- GRADE - Primary Grade (phv00544004.v1.p1)
- HISTOLOGY - Primary histology (phv00544003.v1.p1)
- IS_TUMOR - Tumor status (phv00544001.v1.p1)
- TEMOZOLOMIDE_THERAPY - Temozolomide therapy (phv00543998.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00543996.v1.p1)
- RACE - Self-reported race (phv00543995.v1.p1)
Other (9)
- ANALYTE_TYPE - Analyte Type (phv00544000.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00544005.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00543989.v1.p1)
- PRIMARY_RECURRENT_TUMOR - Primary tumor, recurrent tumor (phv00544002.v1.p1)
- SAMPLE_ID - Sample ID (phv00543999.v1.p1)
- SAMPLE_ID - Sample ID (phv00543992.v1.p1)
- SUBJECT_ID - Subject ID (phv00543993.v1.p1)
- SUBJECT_ID - Subject ID (phv00543988.v1.p1)
- SUBJECT_ID - Subject ID (phv00543991.v1.p1)